Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China flag China · Delayed Price · Currency is CNY
18.73
+0.39 (2.13%)
Apr 1, 2026, 3:04 PM CST

SHE:300482 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
8,70110,70913,33814,08817,52230,571
Market Cap Growth
-22.49%-19.71%-5.32%-19.60%-42.68%72.31%
Enterprise Value
7,7469,27812,06313,30916,88929,510
Last Close Price
18.7322.0029.1930.3337.1964.48
PE Ratio
34.2619.0727.3511.7727.6248.21
Forward PE
34.3714.6421.8612.4919.7440.75
PS Ratio
3.383.494.822.485.2110.88
PB Ratio
1.561.902.893.115.0010.21
P/TBV Ratio
1.682.053.173.505.6511.70
P/FCF Ratio
928.02246.19-12.8284.0647.59
P/OCF Ratio
36.0929.6140.588.3826.3528.79
EV/Sales Ratio
3.013.034.362.345.0310.50
EV/EBITDA Ratio
18.8611.6517.018.4820.6630.57
EV/EBIT Ratio
35.8815.7226.4110.0526.6135.75
EV/FCF Ratio
826.15213.29-12.1181.0345.94
Debt / Equity Ratio
0.110.110.130.170.170.20
Debt / EBITDA Ratio
1.450.740.820.480.690.63
Debt / FCF Ratio
63.6313.92-0.702.790.95
Net Debt / Equity Ratio
-0.18-0.28-0.34-0.34-0.28-0.30
Net Debt / EBITDA Ratio
-2.62-2.00-2.23-0.98-1.21-0.93
Net Debt / FCF Ratio
-108.27-36.6015.20-1.39-4.74-1.40
Asset Turnover
0.380.470.461.020.730.78
Inventory Turnover
2.663.122.776.993.662.90
Quick Ratio
6.594.115.862.552.702.33
Current Ratio
7.784.616.682.943.272.86
Return on Equity (ROE)
4.53%11.01%10.65%29.60%19.47%22.62%
Return on Assets (ROA)
2.01%5.71%4.73%14.84%8.66%14.23%
Return on Invested Capital (ROIC)
4.53%14.95%13.63%41.83%25.59%38.48%
Return on Capital Employed (ROCE)
3.50%9.30%8.60%25.70%15.60%23.50%
Earnings Yield
2.98%5.24%3.66%8.50%3.62%2.07%
FCF Yield
0.11%0.41%-0.78%7.80%1.19%2.10%
Dividend Yield
2.18%1.82%1.37%1.65%0.81%0.60%
Payout Ratio
78.15%34.93%46.75%11.73%27.38%14.14%
Buyback Yield / Dilution
-2.81%-4.71%-0.36%0.44%-0.74%0.33%
Total Shareholder Return
-0.64%-2.89%1.01%2.09%0.07%0.93%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.